Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2010-12-24

AUTHORS

S. Vasikaran, R. Eastell, O. Bruyère, A. J. Foldes, P. Garnero, A. Griesmacher, M. McClung, H. A. Morris, S. Silverman, T. Trenti, D. A. Wahl, C. Cooper, J. A. Kanis, for the IOF-IFCC Bone Marker Standards Working Group

ABSTRACT

The International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) recommend that a marker of bone formation (serum procollagen type I N propeptide, s-PINP) and a marker of bone resorption (serum C-terminal telopeptide of type I collagen, s-CTX) are used as reference analytes for bone turnover markers in clinical studies.IntroductionBone turnover markers (BTM) predict fracture risk, and treatment-induced changes in specific markers account for a substantial proportion of fracture risk reduction. The aims of this report were to determine their clinical potential in the prediction of fracture risk and for monitoring the treatment of osteoporosis and to set an appropriate research agenda.MethodsEvidence from prospective studies was gathered through literature review of the PUBMED database between the years 2000 and 2010 and the systematic review of the Agency for Healthcare Research and Quality up to 2001.ResultsHigh levels of BTMs may predict fracture risk independently from bone mineral density in postmenopausal women. They have been used for this purpose in clinical practice for many years, but there is still a need for stronger evidence on which to base practice. BTMs provide pharmacodynamic information on the response to osteoporosis treatment, and as a result, they are widely used for monitoring treatment in the individual. However, their clinical value for monitoring is limited by inadequate appreciation of the sources of variability, by limited data for comparison of treatments using the same BTM and by inadequate quality control. IOF/IFCC recommend one bone formation marker (s-PINP) and one bone resorption marker (s-CTX) to be used as reference markers and measured by standardised assays in observational and intervention studies in order to compare the performance of alternatives and to enlarge the international experience of the application of markers to clinical medicine.ConclusionBTM hold promise in fracture risk prediction and for monitoring treatment. Uncertainties over their clinical use can be in part resolved by adopting international reference standards. More... »

PAGES

391-420

References to SciGraph publications

  • 2008-05-10. Determinants of Bone Turnover Markers in Healthy Premenopausal Women in CALCIFIED TISSUE INTERNATIONAL
  • 2000-02. Predictors of Fractures in Elderly Women in OSTEOPOROSIS INTERNATIONAL
  • 2000-01. Serum Bone Alkaline Phosphatase and Calcaneus Bone Density Predict Fractures: A Prospective Study in OSTEOPOROSIS INTERNATIONAL
  • 2010-06-09. The utility of BMD Z-score diagnostic thresholds for secondary causes of osteoporosis in OSTEOPOROSIS INTERNATIONAL
  • 2000-03. Risk Factors for Perimenopausal Fractures: A Prospective Study in OSTEOPOROSIS INTERNATIONAL
  • 2005-12-15. Changes in bone mass and bone turnover following tibial shaft fracture in OSTEOPOROSIS INTERNATIONAL
  • 2004-04-08. Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study in OSTEOPOROSIS INTERNATIONAL
  • 2009-06-11. FRAX® assessment of osteoporotic fracture probability in Switzerland in OSTEOPOROSIS INTERNATIONAL
  • 2009-10-08. Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years in OSTEOPOROSIS INTERNATIONAL
  • 1991-02. Potential risk factors for development of postmenopausal osteoporosis — Examined over a 12-year period in OSTEOPOROSIS INTERNATIONAL
  • 2002-07. Biochemical Indices of Bone Turnover and the Assessment of Fracture Probability in OSTEOPOROSIS INTERNATIONAL
  • 2002-07. A New Approach to the Development of Assessment Guidelines for Osteoporosis in OSTEOPOROSIS INTERNATIONAL
  • 1996-04. Bone density change and biochemical indices of skeletal turnover in CALCIFIED TISSUE INTERNATIONAL
  • 1981-12. Mean wall thickness and formation periods of trabecular bone packets in idiopathic osteoporosis in CALCIFIED TISSUE INTERNATIONAL
  • 2000-12. Preanalytical Variability of Biochemical Markers of Bone Turnover in OSTEOPOROSIS INTERNATIONAL
  • 2008-02-22. Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™) in OSTEOPOROSIS INTERNATIONAL
  • 2000-12. The Use of Biochemical Markers of Bone Turnover in Osteoporosis in OSTEOPOROSIS INTERNATIONAL
  • 1995-08. Evolution of spinal bone loss and biochemical markers of bone remodeling after menopause in normal women in CALCIFIED TISSUE INTERNATIONAL
  • 2001-11. Six and Twelve Month Changes in Bone Turnover are Related to Reduction in Vertebral Fracture Risk During 3 Years of Raloxifene Treatment in Postmenopausal Osteoporosis in OSTEOPOROSIS INTERNATIONAL
  • 1990-10. Screening procedure for women at risk of developing postmenopausal osteoporosis in OSTEOPOROSIS INTERNATIONAL
  • 2006-08-16. An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 1998-05. Association Between Female Sex Hormones and Biochemical Markers of Bone Turnover in Peri- and Postmenopausal Women in CALCIFIED TISSUE INTERNATIONAL
  • 2008-02-12. European guidance for the diagnosis and management of osteoporosis in postmenopausal women in OSTEOPOROSIS INTERNATIONAL
  • 2009-05-13. Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover in OSTEOPOROSIS INTERNATIONAL
  • 2008-07-16. Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis in OSTEOPOROSIS INTERNATIONAL
  • 2009-02-04. Bone turnover markers: understanding their value in clinical trials and clinical practice in OSTEOPOROSIS INTERNATIONAL
  • 2009-11-25. Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study in OSTEOPOROSIS INTERNATIONAL
  • 2004-12-24. Requirements for DXA for the management of osteoporosis in Europe in OSTEOPOROSIS INTERNATIONAL
  • Journal

    TITLE

    Osteoporosis International

    ISSUE

    2

    VOLUME

    22

    Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s00198-010-1501-1

    DOI

    http://dx.doi.org/10.1007/s00198-010-1501-1

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1044145841

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/21184054


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged, 80 and over", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Algorithms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Biomarkers", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Bone Density", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Bone Remodeling", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Osteoporosis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Osteoporosis, Postmenopausal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Osteoporotic Fractures", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Reference Standards", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Risk Assessment", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Treatment Outcome", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "School of Pathology and Laboratory Medicine, University of Western Australia, Nedlands, WA, Australia", 
              "id": "http://www.grid.ac/institutes/grid.1012.2", 
              "name": [
                "Department of Core Clinical Pathology and Biochemistry, PathWest Laboratory Medicine, Royal Perth Hospital, Perth, WA, Australia", 
                "School of Pathology and Laboratory Medicine, University of Western Australia, Nedlands, WA, Australia"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Vasikaran", 
            "givenName": "S.", 
            "id": "sg:person.01175332754.44", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175332754.44"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Centre for Biomedical Research, Northern General Hospital, Herries Road, S5 7AU, Sheffield, South Yorkshire, England, UK", 
              "id": "http://www.grid.ac/institutes/grid.412937.a", 
              "name": [
                "Centre for Biomedical Research, Northern General Hospital, Herries Road, S5 7AU, Sheffield, South Yorkshire, England, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Eastell", 
            "givenName": "R.", 
            "id": "sg:person.0100521534.43", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0100521534.43"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Public Health, Epidemiology and Health Economics, University of Li\u00e8ge, Li\u00e8ge, Belgium", 
              "id": "http://www.grid.ac/institutes/grid.4861.b", 
              "name": [
                "Department of Public Health, Epidemiology and Health Economics, University of Li\u00e8ge, Li\u00e8ge, Belgium"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bruy\u00e8re", 
            "givenName": "O.", 
            "id": "sg:person.01234306547.54", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234306547.54"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Osteoporosis Center, Hadassah University Hospital, Mount Scopus, 91240, Jerusalem, Israel", 
              "id": "http://www.grid.ac/institutes/grid.17788.31", 
              "name": [
                "Osteoporosis Center, Hadassah University Hospital, Mount Scopus, 91240, Jerusalem, Israel"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Foldes", 
            "givenName": "A. J.", 
            "id": "sg:person.01351040403.82", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351040403.82"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "INSERM Unit 664, Lyon, France", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "INSERM Unit 664, Lyon, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Garnero", 
            "givenName": "P.", 
            "id": "sg:person.01337464403.01", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337464403.01"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Central Institute of Medical and Chemical Laboratory Diagnostics, University Hospital of Innsbruck, 6080, Innsbruck, Austria", 
              "id": "http://www.grid.ac/institutes/grid.410706.4", 
              "name": [
                "Central Institute of Medical and Chemical Laboratory Diagnostics, University Hospital of Innsbruck, 6080, Innsbruck, Austria"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Griesmacher", 
            "givenName": "A.", 
            "id": "sg:person.0653325641.42", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653325641.42"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Oregon Osteoporosis Center, 5050 NE Hoyt Street, Suite 651, 97213, Portland, OR, USA", 
              "id": "http://www.grid.ac/institutes/grid.240531.1", 
              "name": [
                "Oregon Osteoporosis Center, 5050 NE Hoyt Street, Suite 651, 97213, Portland, OR, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "McClung", 
            "givenName": "M.", 
            "id": "sg:person.01202365465.00", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202365465.00"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "School of Pharmacy and Medical Sciences, University of South Australia, 5000, Adelaide, SA, Australia", 
              "id": "http://www.grid.ac/institutes/grid.1026.5", 
              "name": [
                "School of Pharmacy and Medical Sciences, University of South Australia, 5000, Adelaide, SA, Australia"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Morris", 
            "givenName": "H. A.", 
            "id": "sg:person.01030064305.01", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030064305.01"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cedars-Sinai/University of California, Los Angeles, CA, USA", 
              "id": "http://www.grid.ac/institutes/grid.19006.3e", 
              "name": [
                "Cedars-Sinai/University of California, Los Angeles, CA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Silverman", 
            "givenName": "S.", 
            "id": "sg:person.0750301114.52", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750301114.52"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Patologia Clinica, Tossicologia e Diagnostica Avanzata, Dipartimento di Patologia Clinica, Ospedale Nuovo Sant\u2019Agostino Estense, via Giardini 1355, 4110, Modena, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Patologia Clinica, Tossicologia e Diagnostica Avanzata, Dipartimento di Patologia Clinica, Ospedale Nuovo Sant\u2019Agostino Estense, via Giardini 1355, 4110, Modena, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Trenti", 
            "givenName": "T.", 
            "id": "sg:person.016305713433.58", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016305713433.58"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "International Osteoporosis Foundation, Nyon, Switzerland", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "International Osteoporosis Foundation, Nyon, Switzerland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wahl", 
            "givenName": "D. A.", 
            "id": "sg:person.0622727433.54", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622727433.54"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "NIHR Musculoskeletal Biomedical Research Unit, Institute of Musculoskeletal Sciences, University of Oxford, OX3 7LD, Oxford, UK", 
              "id": "http://www.grid.ac/institutes/grid.4991.5", 
              "name": [
                "MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, SO16 6YD, Southampton, UK", 
                "NIHR Musculoskeletal Biomedical Research Unit, Institute of Musculoskeletal Sciences, University of Oxford, OX3 7LD, Oxford, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cooper", 
            "givenName": "C.", 
            "id": "sg:person.01154357674.52", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154357674.52"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Centre for Metabolic Bone Diseases (WHO Collaborating Centre), University of Sheffield Medical School, Beech Hill Road, S10 2RX, Sheffield, UK", 
              "id": "http://www.grid.ac/institutes/grid.11835.3e", 
              "name": [
                "Centre for Metabolic Bone Diseases (WHO Collaborating Centre), University of Sheffield Medical School, Beech Hill Road, S10 2RX, Sheffield, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kanis", 
            "givenName": "J. A.", 
            "id": "sg:person.0663427426.32", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663427426.32"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "for the IOF-IFCC Bone Marker Standards Working Group", 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s001980050009", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042493026", 
              "https://doi.org/10.1007/s001980050009"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001980070004", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022005652", 
              "https://doi.org/10.1007/s001980070004"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf01880450", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002944999", 
              "https://doi.org/10.1007/bf01880450"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001980200068", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043812640", 
              "https://doi.org/10.1007/s001980200068"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-009-0838-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014340593", 
              "https://doi.org/10.1007/s00198-009-0838-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf02409438", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047093168", 
              "https://doi.org/10.1007/bf02409438"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-009-0975-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013633075", 
              "https://doi.org/10.1007/s00198-009-0975-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-005-2025-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052259550", 
              "https://doi.org/10.1007/s00198-005-2025-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-008-0560-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000501834", 
              "https://doi.org/10.1007/s00198-008-0560-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-004-1602-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036604057", 
              "https://doi.org/10.1007/s00198-004-1602-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-007-0544-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021197386", 
              "https://doi.org/10.1007/s00198-007-0544-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf01880414", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032171571", 
              "https://doi.org/10.1007/bf01880414"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-009-1078-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017865228", 
              "https://doi.org/10.1007/s00198-009-1078-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s002239900450", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017259414", 
              "https://doi.org/10.1007/s002239900450"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-010-1307-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025923527", 
              "https://doi.org/10.1007/s00198-010-1307-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00298429", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000963044", 
              "https://doi.org/10.1007/bf00298429"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-004-1811-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033148553", 
              "https://doi.org/10.1007/s00198-004-1811-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-008-0660-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002143137", 
              "https://doi.org/10.1007/s00198-008-0660-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001980070002", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025267804", 
              "https://doi.org/10.1007/s001980070002"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-009-1127-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000441845", 
              "https://doi.org/10.1007/s00198-009-1127-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00228-006-0174-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017268550", 
              "https://doi.org/10.1007/s00228-006-0174-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001980170020", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051252526", 
              "https://doi.org/10.1007/s001980170020"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/pl00004174", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020210098", 
              "https://doi.org/10.1007/pl00004174"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-009-0940-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026001642", 
              "https://doi.org/10.1007/s00198-009-0940-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00223-008-9126-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009110185", 
              "https://doi.org/10.1007/s00223-008-9126-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001980050284", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020074736", 
              "https://doi.org/10.1007/s001980050284"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf02508642", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041509001", 
              "https://doi.org/10.1007/bf02508642"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001980200069", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001135478", 
              "https://doi.org/10.1007/s001980200069"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2010-12-24", 
        "datePublishedReg": "2010-12-24", 
        "description": "The International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) recommend that a marker of bone formation (serum procollagen type I N propeptide, s-PINP) and a marker of bone resorption (serum C-terminal telopeptide of type I collagen, s-CTX) are used as reference analytes for bone turnover markers in clinical studies.IntroductionBone turnover markers (BTM) predict fracture risk, and treatment-induced changes in specific markers account for a substantial proportion of fracture risk reduction. The aims of this report were to determine their clinical potential in the prediction of fracture risk and for monitoring the treatment of osteoporosis and to set an appropriate research agenda.MethodsEvidence from prospective studies was gathered through literature review of the PUBMED database between the years 2000 and 2010 and the systematic review of the Agency for Healthcare Research and Quality up to 2001.ResultsHigh levels of BTMs may predict fracture risk independently from bone mineral density in postmenopausal women. They have been used for this purpose in clinical practice for many years, but there is still a need for stronger evidence on which to base practice. BTMs provide pharmacodynamic information on the response to osteoporosis treatment, and as a result, they are widely used for monitoring treatment in the individual. However, their clinical value for monitoring is limited by inadequate appreciation of the sources of variability, by limited data for comparison of treatments using the same BTM and by inadequate quality control. IOF/IFCC recommend one bone formation marker (s-PINP) and one bone resorption marker (s-CTX) to be used as reference markers and measured by standardised assays in observational and intervention studies in order to compare the performance of alternatives and to enlarge the international experience of the application of markers to clinical medicine.ConclusionBTM hold promise in fracture risk prediction and for monitoring treatment. Uncertainties over their clinical use can be in part resolved by adopting international reference standards.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s00198-010-1501-1", 
        "isAccessibleForFree": false, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2783241", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1100834", 
            "issn": [
              "0937-941X", 
              "1433-2965"
            ], 
            "name": "Osteoporosis International", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "2", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "22"
          }
        ], 
        "keywords": [
          "International Osteoporosis Foundation", 
          "fracture risk", 
          "turnover markers", 
          "osteoporosis treatment", 
          "fracture risk reduction", 
          "bone turnover markers", 
          "bone resorption markers", 
          "bone formation markers", 
          "treatment of osteoporosis", 
          "bone mineral density", 
          "reference standard", 
          "international reference standards", 
          "treatment-induced changes", 
          "IntroductionBone turnover markers", 
          "fracture risk prediction", 
          "comparison of treatments", 
          "postmenopausal women", 
          "resorption markers", 
          "prospective study", 
          "formation markers", 
          "bone turnover", 
          "bone resorption", 
          "mineral density", 
          "clinical studies", 
          "clinical value", 
          "clinical practice", 
          "pharmacodynamic information", 
          "PubMed database", 
          "intervention studies", 
          "systematic review", 
          "clinical use", 
          "Healthcare Research", 
          "clinical potential", 
          "bone formation", 
          "specific markers", 
          "risk prediction", 
          "standardised assays", 
          "substantial proportion", 
          "International Federation", 
          "limited data", 
          "treatment", 
          "risk reduction", 
          "risk", 
          "markers", 
          "clinical chemistry", 
          "clinical medicine", 
          "hold promise", 
          "appropriate research agenda", 
          "literature review", 
          "laboratory medicine", 
          "medicine", 
          "review", 
          "osteoporosis", 
          "reference markers", 
          "strong evidence", 
          "resorption", 
          "inadequate quality control", 
          "MethodsEvidence", 
          "year 2000", 
          "BTM", 
          "women", 
          "study", 
          "report", 
          "sources of variability", 
          "assays", 
          "application of marker", 
          "aim", 
          "years", 
          "proportion", 
          "inadequate appreciation", 
          "monitoring", 
          "need", 
          "individuals", 
          "practice", 
          "response", 
          "evidence", 
          "levels", 
          "database", 
          "control", 
          "standards", 
          "reduction", 
          "turnover", 
          "IFCC", 
          "experience", 
          "changes", 
          "use", 
          "promise", 
          "purpose", 
          "quality control", 
          "data", 
          "quality", 
          "alternative", 
          "potential", 
          "comparison", 
          "variability", 
          "research agenda", 
          "results", 
          "reference analytes", 
          "appreciation", 
          "part", 
          "information", 
          "Federation", 
          "values", 
          "research", 
          "agencies", 
          "formation", 
          "prediction", 
          "BTMS", 
          "international experience", 
          "source", 
          "order", 
          "density", 
          "analytes", 
          "foundation", 
          "agenda", 
          "applications", 
          "performance", 
          "uncertainty", 
          "chemistry", 
          "performance of alternatives"
        ], 
        "name": "Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards", 
        "pagination": "391-420", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1044145841"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s00198-010-1501-1"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "21184054"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s00198-010-1501-1", 
          "https://app.dimensions.ai/details/publication/pub.1044145841"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-12-01T06:28", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_513.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s00198-010-1501-1"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00198-010-1501-1'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00198-010-1501-1'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00198-010-1501-1'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00198-010-1501-1'


     

    This table displays all metadata directly associated to this object as RDF triples.

    487 TRIPLES      21 PREDICATES      190 URIs      154 LITERALS      24 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s00198-010-1501-1 schema:about N0f6a17e1d92a4f5db6368ae82fced6b5
    2 N1d12c3a10fd4487787dffb6de14e6a1c
    3 N3147e543500f438ca203fcebdab59721
    4 N3d592be36cc44f97adf3a4a6a5745c49
    5 N6aa640b12cab49dfb3830710c0353764
    6 N7b43f84817544d4392b0c8f29eaa1898
    7 N90415205f93c46a78a2fc648673095c3
    8 N9cc6a0e3df0d4802b440aee09c7e24ea
    9 Na4aee73a870e4d5fa284f6f364f7d401
    10 Nb0d4c5925337411b9ceeda5ccba8dc26
    11 Nd25452b47ac242f583736236958dddd0
    12 Ndb997ecdeb7f45dc93ade415e1c26dc0
    13 Ndff7ad00a4914e699c386d9fa96eedaa
    14 Ne294cc9373dc445fae95cb9fb4ddbfa7
    15 Ne8f95c36ebfd4fdeb47080d6bdd67da7
    16 Ned64dbddd7314ac3b079b7ea51c47d2a
    17 Nf83838667e94479085190b68dff80dc4
    18 anzsrc-for:11
    19 anzsrc-for:1103
    20 schema:author Nafb5c1748ee94009a11967e670c1dabb
    21 schema:citation sg:pub.10.1007/bf00298429
    22 sg:pub.10.1007/bf01880414
    23 sg:pub.10.1007/bf01880450
    24 sg:pub.10.1007/bf02409438
    25 sg:pub.10.1007/bf02508642
    26 sg:pub.10.1007/pl00004174
    27 sg:pub.10.1007/s00198-004-1602-9
    28 sg:pub.10.1007/s00198-004-1811-2
    29 sg:pub.10.1007/s00198-005-2025-y
    30 sg:pub.10.1007/s00198-007-0544-4
    31 sg:pub.10.1007/s00198-008-0560-z
    32 sg:pub.10.1007/s00198-008-0660-9
    33 sg:pub.10.1007/s00198-009-0838-9
    34 sg:pub.10.1007/s00198-009-0940-z
    35 sg:pub.10.1007/s00198-009-0975-1
    36 sg:pub.10.1007/s00198-009-1078-8
    37 sg:pub.10.1007/s00198-009-1127-3
    38 sg:pub.10.1007/s00198-010-1307-1
    39 sg:pub.10.1007/s001980050009
    40 sg:pub.10.1007/s001980050284
    41 sg:pub.10.1007/s001980070002
    42 sg:pub.10.1007/s001980070004
    43 sg:pub.10.1007/s001980170020
    44 sg:pub.10.1007/s001980200068
    45 sg:pub.10.1007/s001980200069
    46 sg:pub.10.1007/s00223-008-9126-5
    47 sg:pub.10.1007/s002239900450
    48 sg:pub.10.1007/s00228-006-0174-3
    49 schema:datePublished 2010-12-24
    50 schema:datePublishedReg 2010-12-24
    51 schema:description The International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) recommend that a marker of bone formation (serum procollagen type I N propeptide, s-PINP) and a marker of bone resorption (serum C-terminal telopeptide of type I collagen, s-CTX) are used as reference analytes for bone turnover markers in clinical studies.IntroductionBone turnover markers (BTM) predict fracture risk, and treatment-induced changes in specific markers account for a substantial proportion of fracture risk reduction. The aims of this report were to determine their clinical potential in the prediction of fracture risk and for monitoring the treatment of osteoporosis and to set an appropriate research agenda.MethodsEvidence from prospective studies was gathered through literature review of the PUBMED database between the years 2000 and 2010 and the systematic review of the Agency for Healthcare Research and Quality up to 2001.ResultsHigh levels of BTMs may predict fracture risk independently from bone mineral density in postmenopausal women. They have been used for this purpose in clinical practice for many years, but there is still a need for stronger evidence on which to base practice. BTMs provide pharmacodynamic information on the response to osteoporosis treatment, and as a result, they are widely used for monitoring treatment in the individual. However, their clinical value for monitoring is limited by inadequate appreciation of the sources of variability, by limited data for comparison of treatments using the same BTM and by inadequate quality control. IOF/IFCC recommend one bone formation marker (s-PINP) and one bone resorption marker (s-CTX) to be used as reference markers and measured by standardised assays in observational and intervention studies in order to compare the performance of alternatives and to enlarge the international experience of the application of markers to clinical medicine.ConclusionBTM hold promise in fracture risk prediction and for monitoring treatment. Uncertainties over their clinical use can be in part resolved by adopting international reference standards.
    52 schema:genre article
    53 schema:isAccessibleForFree false
    54 schema:isPartOf N0c63d8a40a0b460ba1d6afa244c875e6
    55 Nb4971fe50c984b5b8c8b92287c7c5c75
    56 sg:journal.1100834
    57 schema:keywords BTM
    58 BTMS
    59 Federation
    60 Healthcare Research
    61 IFCC
    62 International Federation
    63 International Osteoporosis Foundation
    64 IntroductionBone turnover markers
    65 MethodsEvidence
    66 PubMed database
    67 agencies
    68 agenda
    69 aim
    70 alternative
    71 analytes
    72 application of marker
    73 applications
    74 appreciation
    75 appropriate research agenda
    76 assays
    77 bone formation
    78 bone formation markers
    79 bone mineral density
    80 bone resorption
    81 bone resorption markers
    82 bone turnover
    83 bone turnover markers
    84 changes
    85 chemistry
    86 clinical chemistry
    87 clinical medicine
    88 clinical potential
    89 clinical practice
    90 clinical studies
    91 clinical use
    92 clinical value
    93 comparison
    94 comparison of treatments
    95 control
    96 data
    97 database
    98 density
    99 evidence
    100 experience
    101 formation
    102 formation markers
    103 foundation
    104 fracture risk
    105 fracture risk prediction
    106 fracture risk reduction
    107 hold promise
    108 inadequate appreciation
    109 inadequate quality control
    110 individuals
    111 information
    112 international experience
    113 international reference standards
    114 intervention studies
    115 laboratory medicine
    116 levels
    117 limited data
    118 literature review
    119 markers
    120 medicine
    121 mineral density
    122 monitoring
    123 need
    124 order
    125 osteoporosis
    126 osteoporosis treatment
    127 part
    128 performance
    129 performance of alternatives
    130 pharmacodynamic information
    131 postmenopausal women
    132 potential
    133 practice
    134 prediction
    135 promise
    136 proportion
    137 prospective study
    138 purpose
    139 quality
    140 quality control
    141 reduction
    142 reference analytes
    143 reference markers
    144 reference standard
    145 report
    146 research
    147 research agenda
    148 resorption
    149 resorption markers
    150 response
    151 results
    152 review
    153 risk
    154 risk prediction
    155 risk reduction
    156 source
    157 sources of variability
    158 specific markers
    159 standardised assays
    160 standards
    161 strong evidence
    162 study
    163 substantial proportion
    164 systematic review
    165 treatment
    166 treatment of osteoporosis
    167 treatment-induced changes
    168 turnover
    169 turnover markers
    170 uncertainty
    171 use
    172 values
    173 variability
    174 women
    175 year 2000
    176 years
    177 schema:name Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
    178 schema:pagination 391-420
    179 schema:productId N3314658c6fdd4b72866f96ee37e5390f
    180 N5b816300b2414b28857f8741147f54b8
    181 Nd90c8d53233f4949a6538915e25f8796
    182 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044145841
    183 https://doi.org/10.1007/s00198-010-1501-1
    184 schema:sdDatePublished 2022-12-01T06:28
    185 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    186 schema:sdPublisher N9bbf76e2b12b44c68180fd1b0dc3291d
    187 schema:url https://doi.org/10.1007/s00198-010-1501-1
    188 sgo:license sg:explorer/license/
    189 sgo:sdDataset articles
    190 rdf:type schema:ScholarlyArticle
    191 N0247d3eef6a646599179a5c0e80c30c2 rdf:first sg:person.01234306547.54
    192 rdf:rest Nd3816ebc1b2e499b9038510a7a9f32d5
    193 N051f5b4c0cee453d8f4fcfd70512f0f3 rdf:first sg:person.01337464403.01
    194 rdf:rest N8443d99b49fe464fa2e81ec4d5f40d44
    195 N0707b0ca94e4444db7501f6ddda6516b rdf:first sg:person.016305713433.58
    196 rdf:rest N15e1430b388c48cf9cc48d85672ea33c
    197 N0c63d8a40a0b460ba1d6afa244c875e6 schema:volumeNumber 22
    198 rdf:type schema:PublicationVolume
    199 N0f6a17e1d92a4f5db6368ae82fced6b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    200 schema:name Male
    201 rdf:type schema:DefinedTerm
    202 N14d470af45f64a0ca762ff871bafcb69 rdf:first sg:person.01202365465.00
    203 rdf:rest Ne4afdca47b3e453093ad1b55c9468934
    204 N15e1430b388c48cf9cc48d85672ea33c rdf:first sg:person.0622727433.54
    205 rdf:rest N721f927bc8dd400ca7d515fe578162cd
    206 N1d12c3a10fd4487787dffb6de14e6a1c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    207 schema:name Biomarkers
    208 rdf:type schema:DefinedTerm
    209 N3147e543500f438ca203fcebdab59721 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    210 schema:name Adult
    211 rdf:type schema:DefinedTerm
    212 N3314658c6fdd4b72866f96ee37e5390f schema:name doi
    213 schema:value 10.1007/s00198-010-1501-1
    214 rdf:type schema:PropertyValue
    215 N3d592be36cc44f97adf3a4a6a5745c49 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    216 schema:name Humans
    217 rdf:type schema:DefinedTerm
    218 N3f13db9795f84e47a702e191e2bc08e5 rdf:first Ne7f393c50d6047dfbd1c60faa19e28ae
    219 rdf:rest rdf:nil
    220 N48e4a55bede441bf80da062f1993449c rdf:first sg:person.0750301114.52
    221 rdf:rest N0707b0ca94e4444db7501f6ddda6516b
    222 N4a94b938372544d7b77ee4ac01f02252 rdf:first sg:person.0663427426.32
    223 rdf:rest N3f13db9795f84e47a702e191e2bc08e5
    224 N5b816300b2414b28857f8741147f54b8 schema:name pubmed_id
    225 schema:value 21184054
    226 rdf:type schema:PropertyValue
    227 N6aa640b12cab49dfb3830710c0353764 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    228 schema:name Osteoporotic Fractures
    229 rdf:type schema:DefinedTerm
    230 N721f927bc8dd400ca7d515fe578162cd rdf:first sg:person.01154357674.52
    231 rdf:rest N4a94b938372544d7b77ee4ac01f02252
    232 N7b43f84817544d4392b0c8f29eaa1898 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    233 schema:name Female
    234 rdf:type schema:DefinedTerm
    235 N8443d99b49fe464fa2e81ec4d5f40d44 rdf:first sg:person.0653325641.42
    236 rdf:rest N14d470af45f64a0ca762ff871bafcb69
    237 N90415205f93c46a78a2fc648673095c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    238 schema:name Middle Aged
    239 rdf:type schema:DefinedTerm
    240 N9bbf76e2b12b44c68180fd1b0dc3291d schema:name Springer Nature - SN SciGraph project
    241 rdf:type schema:Organization
    242 N9cc6a0e3df0d4802b440aee09c7e24ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    243 schema:name Reference Standards
    244 rdf:type schema:DefinedTerm
    245 Na4aee73a870e4d5fa284f6f364f7d401 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    246 schema:name Treatment Outcome
    247 rdf:type schema:DefinedTerm
    248 Nafb5c1748ee94009a11967e670c1dabb rdf:first sg:person.01175332754.44
    249 rdf:rest Nf23e305688c44dc7929a66648657c1cd
    250 Nb0d4c5925337411b9ceeda5ccba8dc26 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    251 schema:name Aged, 80 and over
    252 rdf:type schema:DefinedTerm
    253 Nb4971fe50c984b5b8c8b92287c7c5c75 schema:issueNumber 2
    254 rdf:type schema:PublicationIssue
    255 Nd25452b47ac242f583736236958dddd0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    256 schema:name Algorithms
    257 rdf:type schema:DefinedTerm
    258 Nd3816ebc1b2e499b9038510a7a9f32d5 rdf:first sg:person.01351040403.82
    259 rdf:rest N051f5b4c0cee453d8f4fcfd70512f0f3
    260 Nd90c8d53233f4949a6538915e25f8796 schema:name dimensions_id
    261 schema:value pub.1044145841
    262 rdf:type schema:PropertyValue
    263 Ndb997ecdeb7f45dc93ade415e1c26dc0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    264 schema:name Aged
    265 rdf:type schema:DefinedTerm
    266 Ndff7ad00a4914e699c386d9fa96eedaa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    267 schema:name Osteoporosis
    268 rdf:type schema:DefinedTerm
    269 Ne294cc9373dc445fae95cb9fb4ddbfa7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    270 schema:name Bone Density
    271 rdf:type schema:DefinedTerm
    272 Ne4afdca47b3e453093ad1b55c9468934 rdf:first sg:person.01030064305.01
    273 rdf:rest N48e4a55bede441bf80da062f1993449c
    274 Ne7f393c50d6047dfbd1c60faa19e28ae schema:familyName for the IOF-IFCC Bone Marker Standards Working Group
    275 rdf:type schema:Person
    276 Ne8f95c36ebfd4fdeb47080d6bdd67da7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    277 schema:name Osteoporosis, Postmenopausal
    278 rdf:type schema:DefinedTerm
    279 Ned64dbddd7314ac3b079b7ea51c47d2a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    280 schema:name Bone Remodeling
    281 rdf:type schema:DefinedTerm
    282 Nf23e305688c44dc7929a66648657c1cd rdf:first sg:person.0100521534.43
    283 rdf:rest N0247d3eef6a646599179a5c0e80c30c2
    284 Nf83838667e94479085190b68dff80dc4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    285 schema:name Risk Assessment
    286 rdf:type schema:DefinedTerm
    287 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    288 schema:name Medical and Health Sciences
    289 rdf:type schema:DefinedTerm
    290 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    291 schema:name Clinical Sciences
    292 rdf:type schema:DefinedTerm
    293 sg:grant.2783241 http://pending.schema.org/fundedItem sg:pub.10.1007/s00198-010-1501-1
    294 rdf:type schema:MonetaryGrant
    295 sg:journal.1100834 schema:issn 0937-941X
    296 1433-2965
    297 schema:name Osteoporosis International
    298 schema:publisher Springer Nature
    299 rdf:type schema:Periodical
    300 sg:person.0100521534.43 schema:affiliation grid-institutes:grid.412937.a
    301 schema:familyName Eastell
    302 schema:givenName R.
    303 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0100521534.43
    304 rdf:type schema:Person
    305 sg:person.01030064305.01 schema:affiliation grid-institutes:grid.1026.5
    306 schema:familyName Morris
    307 schema:givenName H. A.
    308 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030064305.01
    309 rdf:type schema:Person
    310 sg:person.01154357674.52 schema:affiliation grid-institutes:grid.4991.5
    311 schema:familyName Cooper
    312 schema:givenName C.
    313 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154357674.52
    314 rdf:type schema:Person
    315 sg:person.01175332754.44 schema:affiliation grid-institutes:grid.1012.2
    316 schema:familyName Vasikaran
    317 schema:givenName S.
    318 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175332754.44
    319 rdf:type schema:Person
    320 sg:person.01202365465.00 schema:affiliation grid-institutes:grid.240531.1
    321 schema:familyName McClung
    322 schema:givenName M.
    323 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202365465.00
    324 rdf:type schema:Person
    325 sg:person.01234306547.54 schema:affiliation grid-institutes:grid.4861.b
    326 schema:familyName Bruyère
    327 schema:givenName O.
    328 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234306547.54
    329 rdf:type schema:Person
    330 sg:person.01337464403.01 schema:affiliation grid-institutes:None
    331 schema:familyName Garnero
    332 schema:givenName P.
    333 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337464403.01
    334 rdf:type schema:Person
    335 sg:person.01351040403.82 schema:affiliation grid-institutes:grid.17788.31
    336 schema:familyName Foldes
    337 schema:givenName A. J.
    338 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351040403.82
    339 rdf:type schema:Person
    340 sg:person.016305713433.58 schema:affiliation grid-institutes:None
    341 schema:familyName Trenti
    342 schema:givenName T.
    343 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016305713433.58
    344 rdf:type schema:Person
    345 sg:person.0622727433.54 schema:affiliation grid-institutes:None
    346 schema:familyName Wahl
    347 schema:givenName D. A.
    348 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622727433.54
    349 rdf:type schema:Person
    350 sg:person.0653325641.42 schema:affiliation grid-institutes:grid.410706.4
    351 schema:familyName Griesmacher
    352 schema:givenName A.
    353 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653325641.42
    354 rdf:type schema:Person
    355 sg:person.0663427426.32 schema:affiliation grid-institutes:grid.11835.3e
    356 schema:familyName Kanis
    357 schema:givenName J. A.
    358 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663427426.32
    359 rdf:type schema:Person
    360 sg:person.0750301114.52 schema:affiliation grid-institutes:grid.19006.3e
    361 schema:familyName Silverman
    362 schema:givenName S.
    363 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750301114.52
    364 rdf:type schema:Person
    365 sg:pub.10.1007/bf00298429 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000963044
    366 https://doi.org/10.1007/bf00298429
    367 rdf:type schema:CreativeWork
    368 sg:pub.10.1007/bf01880414 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032171571
    369 https://doi.org/10.1007/bf01880414
    370 rdf:type schema:CreativeWork
    371 sg:pub.10.1007/bf01880450 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002944999
    372 https://doi.org/10.1007/bf01880450
    373 rdf:type schema:CreativeWork
    374 sg:pub.10.1007/bf02409438 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047093168
    375 https://doi.org/10.1007/bf02409438
    376 rdf:type schema:CreativeWork
    377 sg:pub.10.1007/bf02508642 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041509001
    378 https://doi.org/10.1007/bf02508642
    379 rdf:type schema:CreativeWork
    380 sg:pub.10.1007/pl00004174 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020210098
    381 https://doi.org/10.1007/pl00004174
    382 rdf:type schema:CreativeWork
    383 sg:pub.10.1007/s00198-004-1602-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036604057
    384 https://doi.org/10.1007/s00198-004-1602-9
    385 rdf:type schema:CreativeWork
    386 sg:pub.10.1007/s00198-004-1811-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033148553
    387 https://doi.org/10.1007/s00198-004-1811-2
    388 rdf:type schema:CreativeWork
    389 sg:pub.10.1007/s00198-005-2025-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1052259550
    390 https://doi.org/10.1007/s00198-005-2025-y
    391 rdf:type schema:CreativeWork
    392 sg:pub.10.1007/s00198-007-0544-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021197386
    393 https://doi.org/10.1007/s00198-007-0544-4
    394 rdf:type schema:CreativeWork
    395 sg:pub.10.1007/s00198-008-0560-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1000501834
    396 https://doi.org/10.1007/s00198-008-0560-z
    397 rdf:type schema:CreativeWork
    398 sg:pub.10.1007/s00198-008-0660-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002143137
    399 https://doi.org/10.1007/s00198-008-0660-9
    400 rdf:type schema:CreativeWork
    401 sg:pub.10.1007/s00198-009-0838-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014340593
    402 https://doi.org/10.1007/s00198-009-0838-9
    403 rdf:type schema:CreativeWork
    404 sg:pub.10.1007/s00198-009-0940-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1026001642
    405 https://doi.org/10.1007/s00198-009-0940-z
    406 rdf:type schema:CreativeWork
    407 sg:pub.10.1007/s00198-009-0975-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013633075
    408 https://doi.org/10.1007/s00198-009-0975-1
    409 rdf:type schema:CreativeWork
    410 sg:pub.10.1007/s00198-009-1078-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017865228
    411 https://doi.org/10.1007/s00198-009-1078-8
    412 rdf:type schema:CreativeWork
    413 sg:pub.10.1007/s00198-009-1127-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000441845
    414 https://doi.org/10.1007/s00198-009-1127-3
    415 rdf:type schema:CreativeWork
    416 sg:pub.10.1007/s00198-010-1307-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025923527
    417 https://doi.org/10.1007/s00198-010-1307-1
    418 rdf:type schema:CreativeWork
    419 sg:pub.10.1007/s001980050009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042493026
    420 https://doi.org/10.1007/s001980050009
    421 rdf:type schema:CreativeWork
    422 sg:pub.10.1007/s001980050284 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020074736
    423 https://doi.org/10.1007/s001980050284
    424 rdf:type schema:CreativeWork
    425 sg:pub.10.1007/s001980070002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025267804
    426 https://doi.org/10.1007/s001980070002
    427 rdf:type schema:CreativeWork
    428 sg:pub.10.1007/s001980070004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022005652
    429 https://doi.org/10.1007/s001980070004
    430 rdf:type schema:CreativeWork
    431 sg:pub.10.1007/s001980170020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051252526
    432 https://doi.org/10.1007/s001980170020
    433 rdf:type schema:CreativeWork
    434 sg:pub.10.1007/s001980200068 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043812640
    435 https://doi.org/10.1007/s001980200068
    436 rdf:type schema:CreativeWork
    437 sg:pub.10.1007/s001980200069 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001135478
    438 https://doi.org/10.1007/s001980200069
    439 rdf:type schema:CreativeWork
    440 sg:pub.10.1007/s00223-008-9126-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009110185
    441 https://doi.org/10.1007/s00223-008-9126-5
    442 rdf:type schema:CreativeWork
    443 sg:pub.10.1007/s002239900450 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017259414
    444 https://doi.org/10.1007/s002239900450
    445 rdf:type schema:CreativeWork
    446 sg:pub.10.1007/s00228-006-0174-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017268550
    447 https://doi.org/10.1007/s00228-006-0174-3
    448 rdf:type schema:CreativeWork
    449 grid-institutes:None schema:alternateName INSERM Unit 664, Lyon, France
    450 International Osteoporosis Foundation, Nyon, Switzerland
    451 Patologia Clinica, Tossicologia e Diagnostica Avanzata, Dipartimento di Patologia Clinica, Ospedale Nuovo Sant’Agostino Estense, via Giardini 1355, 4110, Modena, Italy
    452 schema:name INSERM Unit 664, Lyon, France
    453 International Osteoporosis Foundation, Nyon, Switzerland
    454 Patologia Clinica, Tossicologia e Diagnostica Avanzata, Dipartimento di Patologia Clinica, Ospedale Nuovo Sant’Agostino Estense, via Giardini 1355, 4110, Modena, Italy
    455 rdf:type schema:Organization
    456 grid-institutes:grid.1012.2 schema:alternateName School of Pathology and Laboratory Medicine, University of Western Australia, Nedlands, WA, Australia
    457 schema:name Department of Core Clinical Pathology and Biochemistry, PathWest Laboratory Medicine, Royal Perth Hospital, Perth, WA, Australia
    458 School of Pathology and Laboratory Medicine, University of Western Australia, Nedlands, WA, Australia
    459 rdf:type schema:Organization
    460 grid-institutes:grid.1026.5 schema:alternateName School of Pharmacy and Medical Sciences, University of South Australia, 5000, Adelaide, SA, Australia
    461 schema:name School of Pharmacy and Medical Sciences, University of South Australia, 5000, Adelaide, SA, Australia
    462 rdf:type schema:Organization
    463 grid-institutes:grid.11835.3e schema:alternateName Centre for Metabolic Bone Diseases (WHO Collaborating Centre), University of Sheffield Medical School, Beech Hill Road, S10 2RX, Sheffield, UK
    464 schema:name Centre for Metabolic Bone Diseases (WHO Collaborating Centre), University of Sheffield Medical School, Beech Hill Road, S10 2RX, Sheffield, UK
    465 rdf:type schema:Organization
    466 grid-institutes:grid.17788.31 schema:alternateName Osteoporosis Center, Hadassah University Hospital, Mount Scopus, 91240, Jerusalem, Israel
    467 schema:name Osteoporosis Center, Hadassah University Hospital, Mount Scopus, 91240, Jerusalem, Israel
    468 rdf:type schema:Organization
    469 grid-institutes:grid.19006.3e schema:alternateName Cedars-Sinai/University of California, Los Angeles, CA, USA
    470 schema:name Cedars-Sinai/University of California, Los Angeles, CA, USA
    471 rdf:type schema:Organization
    472 grid-institutes:grid.240531.1 schema:alternateName Oregon Osteoporosis Center, 5050 NE Hoyt Street, Suite 651, 97213, Portland, OR, USA
    473 schema:name Oregon Osteoporosis Center, 5050 NE Hoyt Street, Suite 651, 97213, Portland, OR, USA
    474 rdf:type schema:Organization
    475 grid-institutes:grid.410706.4 schema:alternateName Central Institute of Medical and Chemical Laboratory Diagnostics, University Hospital of Innsbruck, 6080, Innsbruck, Austria
    476 schema:name Central Institute of Medical and Chemical Laboratory Diagnostics, University Hospital of Innsbruck, 6080, Innsbruck, Austria
    477 rdf:type schema:Organization
    478 grid-institutes:grid.412937.a schema:alternateName Centre for Biomedical Research, Northern General Hospital, Herries Road, S5 7AU, Sheffield, South Yorkshire, England, UK
    479 schema:name Centre for Biomedical Research, Northern General Hospital, Herries Road, S5 7AU, Sheffield, South Yorkshire, England, UK
    480 rdf:type schema:Organization
    481 grid-institutes:grid.4861.b schema:alternateName Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium
    482 schema:name Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium
    483 rdf:type schema:Organization
    484 grid-institutes:grid.4991.5 schema:alternateName NIHR Musculoskeletal Biomedical Research Unit, Institute of Musculoskeletal Sciences, University of Oxford, OX3 7LD, Oxford, UK
    485 schema:name MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, SO16 6YD, Southampton, UK
    486 NIHR Musculoskeletal Biomedical Research Unit, Institute of Musculoskeletal Sciences, University of Oxford, OX3 7LD, Oxford, UK
    487 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...